Recent Updates
Recently added Catalysts
CGC

Canopy Growth to Announce Third Quarter Fiscal 2020 Financial Results

Key Takeaway: Canopy Growth to Announce Third Quarter Fiscal 2020 Financial Results SMITHS FALLS, ON, Feb. 7, 2020 /CNW/ - Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) (NYSE: CGC) will release its financial results for the third quarter fiscal 2020 ended Decembe

Full Press Release Details

Canopy Growth to Announce Third Quarter
Fiscal 2020 Financial Results
SMITHS FALLS, ON, Feb. 7, 2020 /CNW/ - Canopy
Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) (NYSE: CGC) will release its financial results
for the third quarter fiscal 2020 ended December 31, 2019 before financial markets open on February 14, 2020.
Following the release of its third quarter
fiscal 2020 financial results, Canopy Growth will host an audio webcast with David Klein, CEO and Mike Lee, EVP & CFO at 10:00
AM Eastern Time on February 14, 2020.
A live audio webcast will be available at:
A replay of the call will be accessible by webcast until 11:59 PM ET on May 14, 2020 at:
About Canopy Growth Corporation
Canopy Growth (TSX:WEED, NYSE:CGC) is a world-leading
diversified cannabis, hemp and cannabis device company, offering distinct brands and curated cannabis varieties in dried, oil and
Softgel capsule forms, as well as medical devices through Canopy Growth's subsidiary, Storz & Bickel GMbH & Co. KG. From
product and process innovation to market execution, Canopy Growth is driven by a passion for leadership and a commitment to building
a world-class cannabis company one product, site and country at a time. Canopy Growth has operations in over a dozen countries
across five continents.
Canopy Growth's medical division, Spectrum
Therapeutics is proudly dedicated to educating healthcare practitioners, conducting robust clinical research, and furthering the
public's understanding of cannabis, and has devoted millions of dollars toward cutting edge, commercializable research and IP development.
Spectrum Therapeutics sells a range of full-spectrum products using its colour-coded classification Spectrum system as well as
single cannabinoid Dronabinol under the brand Bionorica Ethics.
Canopy Growth operates retail stores across
Canada under its award-winning Tweed and Tokyo Smoke banners. Tweed is a globally recognized cannabis brand which has built a large
and loyal following by focusing on quality products and meaningful customer relationships.
From our historic public listing on the Toronto
Stock Exchange and New York Stock Exchange to our continued international expansion, pride in advancing shareholder value through
leadership is engrained in all we do at Canopy Growth. Canopy Growth has established partnerships with leading sector names including
cannabis icons Snoop Dogg and Seth Rogen, breeding legends DNA Genetics and Green House Seeds, and Fortune 500 alcohol leader Constellation
Brands, to name but a few. Canopy Growth operates eleven licensed cannabis production sites with over 4.7 million square feet of
production capacity, including over one million square feet of GMP certified production space. For more information visit www.canopygrowth.com
SOURCE Canopy Growth Corporation
View original content to download multimedia:
For further information: Laura Nadeau, Media Relations, Laura.nadeau@canopygrowth.com,
613-485-0386; Judy Hong, Vice President, Investor Relations (USA), Judy.Hong@canopygrowth.com; Tyler Burns, Vice President, Investor
Relations (Canada), Tyler.Burns@canopygrowth.com, 855-558-9333 ext. 122
CO: Canopy Growth Corporation
CNW 07:00e 07-FEB-20
Last updated: Feb 7, 2020